TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2025-12-17
高憲立Kao, Hsien Li
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
juching2024@gmail.com
發表文獻
53筆
41
Tsai CH, Huang CC, Hsiao HM, Hung MY, Su GJ, Lin LH, Chen YH, Lin MS, Yeh CF, Hung CS, Kao HL(correspondence). Detection of carotid artery stenosis based on video motion analysis for fast screening. J Am Heart Assoc. 2022 Sep 6;11(17):e025702. doi: 10.1161/JAHA.122.025702. Epub 2022 Aug 17.PMID: 35975739
42
Tsai CH, Yeh CF, Meng SW, Hung CS, Lin MS, Huang CC, Chen CK, Huang KP, Chen YH, Kao HL (correspondence). Comparison between drug-coated balloons and drug-coated stents in very small coronary artery interventions. Sci Rep. 2022 Jun 23;12(1):10679. doi: 10.1038/s41598-022-14047-7.PMID: 35739138
43
Wang CH, Chang RW, Wu ET, Chang CY, Kao HL, Wu MS, Cheng YJ, Chen YS, Chang KC. Quantification of cardiac pumping mechanics in rats by using the elastance-resistance model based solely on the measured left ventricular pressure and cardiac output. Pflugers Arch. 2019 Jul;471(7):935-947. doi: 10.1007/s00424-019-02270-7. Epub 2019 Mar 23. PMID: 30904932; PMCID: PMC6591189.
44
Wang SH, Yu TY, Hung CS, Yang CY, Lin MS, Su CY, Chen YL, Kao HL, Chuang LM, Tsai FC, Li HY. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits. Sci Rep. 2018 Jun 18;8(1):9249. doi: 10.1038/s41598-018-27551-6. PMID: 29915377; PMCID: PMC6006253.
45
Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL, Chuang LM, Li HY. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. Transl Res. 2018 Jul;197:12-31. doi: 10.1016/j.trsl.2018.03.001. Epub 2018 Mar 27. PMID: 29653075.
46
Wang TD, Chiang CE, Chao TH, Cheng HM, Wu YW, Wu YJ, Lin YH, Chen MY, Ueng KC, Chang WT, Lee YH, Wang YC, Chu PH, Chao TF, Kao HL, Hou CJ, Lin TH. 2022 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.PMID: 35673334
47
Wang YH, Kao HL, Wang CC, Lin SY, Lin FJ. Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention. Acta Cardiol Sin. 2019 Sep;35(5):508-521. doi: 10.6515/ACS.201909_35(5).20190311A. PMID: 31571800; PMCID: PMC6760126.
48
Wu EB, Brilakis ES, Lo S, Kalyanasundaram A, Mashayekhi K, Kao HL, Lim ST, Ge L, Chen JY, Qian J, Lee SW, Harding SA, Tsuchikane E. Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club. Catheter Cardiovasc Interv. 2020 Dec;96(7):1423-1433. doi: 10.1002/ccd.28607. Epub 2019 Nov 26. PMID: 31769597; PMCID: PMC7754104.
49
Wu EB, Tsuchikane E, Ge L, Harding SA, Lo S, Lim ST, Chen JY, Lee SW, Qian J, Kao HL, Yan BPY. Retrograde Versus Antegrade Approach for Coronary Chronic Total Occlusion in an Algorithm-Driven Contemporary Asia-Pacific Multicentre Registry: Comparison of Outcomes. Heart Lung Circ. 2020 Jun;29(6):894-903. doi: 10.1016/j.hlc.2019.05.188. Epub 2019 Jul 2. PMID: 31320259.
50
Wu EB, Tsuchikane E, Lo S, Lim ST, Ge L, Chen JY, Qian J, Lee SW, Kao HL, Harding SA. Chronic Total Occlusion Wiring: A State-of-the-Art Guide From The Asia Pacific Chronic Total Occlusion Club. Heart Lung Circ. 2019 Oct;28(10):1490-1500. doi: 10.1016/j.hlc.2019.04.004. Epub 2019 Apr 25. PMID: 31128985.
